Contrast Injectors (Global Market)

Main article: Radiology (radiation diagnostics)

2024: Global Contrast Agent Injectors Market Size Up 5.5% to $2.29 Billion for the Year

In 2024, sales of contrast media injectors on a global scale reached $2.29 billion. For comparison, in 2023, the volume of this market was estimated at $2.17 billion. Thus, an increase of 5.5% was recorded, as stated in the Market Research Future review, published at the end of April 2025.

The study looks at medical devices designed to inject contrast agents into a patient's body during diagnostic imaging procedures. Such substances help to improve the visibility of internal organs and tissues when performing computed tomography (CT), magnetic resonance imaging (MRI ), etc.

One of the main drivers of the industry, the authors of the study name the growing demand for advanced diagnostic imaging methods. Specialized injectors deliver the contrast agent to the patient's bloodstream at a controlled rate and under a certain pressure, ensuring its uniform distribution throughout the body. This makes it possible to create clear images with high detail, which helps in identifying a wide range of diseases. As a result, the quality of medical care is improved.

Technological advances have a positive impact on the market. The integration of intelligent features, such as dosage control and automated data collection, enhances injector functionality as well as improves patient safety and comfort. Hospitals and diagnostic centers around the world are introducing advanced imaging complexes, with increasing demand for advanced contrast agent injectors that can integrate with modern diagnostic equipment.

Chronic diseases contribute to the market expansion. As the population ages, health problems become more common, fueling demand for diagnostic imaging procedures. As a result, sales of contrast agent injectors are increasing.

There has been an increase in demand for portable and compact injectors - especially in outpatient facilities and small clinics. In addition, a shift towards sustainability and sustainability is recorded: companies are striving to produce devices that reduce waste and reduce carbon footprint.

Geographically, Market Research Future estimates that North America accounts for the largest share of the industry, accounting for $0.95 billion in 2023. The dominance of the region is due to the high level of development of health infrastructure and the growing demand for diagnostic imaging services. Europe is in second place with costs of $0.6 billion, and the Asia-Pacific region closes the top three with an estimate of $0.38 billion. Another $0.14 billion was provided by South America, approximately $0.1 billion - by the Middle East and Africa. Among the significant players on a global scale are named:

• Konica Minolta;
• Medtronic;
• Neusoft;
• Canon Medical Systems;
• Neusoft Medical Systems;
• Bayer AG;
• Fujifilm Holdings;
• Siemens Healthineers;
• Guerbet S.A.;
• GE Healthcare;
• Bracco Imaging S.p.A;
• Hitachi Medical;
• UltraGenyx Pharmaceutical;
• Hologic.

At the end of 2025, it is expected that sales of contrast agent injectors worldwide will amount to about $2.54 billion. In the future, the CAGR, according to Market Research Future analysts, will be at 5.48%. As a result, by 2034, costs could increase to $4.1 billion.^[1]

2022: Contrast Injectors Market Growth by 7.1% to $1.5 Billion

In 2022, the global market for contrast media injectors reached approximately $1.5 billion. This is 7.1% more than in the previous year, when costs were estimated at $1.4 billion. Such data in mid-January 2023 are given in the Digital Journal study.

The introduction of contrast agents into the bloodstream of patients allows the visualization of various pathologies using X-rays,, and computed tomography (CT) magnetic resonance imaging (MRI) other medical imaging methods. This improves the accuracy and effectiveness of diagnoses in a wide variety of fields, including cardiovascular disease, malignant, formations physical injury and digestive disorders. So the demand for contrast injectors around the world continues to grow.

𝓲

Фото: Pexels

The authors of the study believe that by 2032 the global market for accurate injection of contrast agents will reach $3.1 billion. Thus, the CAGR (compound percentage CAGR) over a ten-year period is expected to be 7.4%. Analysts call radiology the dominant field of application of contrast injectors with a CAGR of about 7.8% until 2032.

The US market is estimated at $1.1 billion with a CAGR of 6.8% from 2022 to 2032. This can be explained by the presence of a developed health infrastructure and the prevalence of chronic diseases. It is expected that in terms of the introduction of contrast injectors, diagnostic imaging centers will continue to lead with a CAGR value of 7.1%. This is due to the growing number of cases of cancer and cardiovascular disease. In addition, advances in the development of simple, efficient and reliable solutions contribute to market expansion.^[2]

2019: Contrast Injectors Market Reaches $1.3 Billion

The volume of the global market for injection systems for the introduction of contrast agents in 2019 reached $1.3 billion, according to data from the analytical company MarketsandMarkets. Experts did not specify the dynamics regarding 2018 and only noted that sales of such devices are growing and will continue to increase at an average rate of about 6.1% per year.

Experts consider the main catalysts for the rise of this market:

• the growing number of cancer and cardiovascular diseases;
• a large number of permits for contrast agents;
• increasing investments, the number of grants and state support in the market.

Contrast Injectors Market Reaches $1.3 Billion for the Year

At the same time, the high cost of such products, consumables and accessories for the contrast injectors market is considered a deterrent. It is consumables that account for most of the revenue in the market, which is associated with safety and hygiene requirements during diagnostic procedures, each of which needs a new consumable.

Depending on the application, contrast injectors are divided into solutions designed for radiology, interventional radiology and interventional cardiology. In 2019, the interventional cardiology segment showed the highest growth rates due to the increasing incidence of cardiovascular ailments in the population.

Most contract injectors are used in hospitals, least in diagnostic centers for medical imaging. Experts attribute the leadership of the hospital to their active desire for digitalization and automation.

According to analysts, the following manufacturers are among the leaders in the global market for contrast injectors (their shares are not indicated):

• Imaxeon Pty;
• Nemoto Kyorindo;
• Guerbet;
• Bracco Imaging;
• Ulrich GmbH & Co;
• Sino Medical-Device Technology.^[3]

2015: Up to $830 million

In early May 2016, the analytical and consulting company GlobalData published the results of a study of the global market for injection systems for the introduction of contrast agents. He was predicted to grow twice by 2022.

According to experts, in 2015, sales of contrast injectors reached $830 million. The largest and fastest growing segment of this market are computed tomography (CT) solutions. Their implementation in the period from 2016 to 2022 will grow by an average of 12.3% annually, while the volume of the global market for injection systems - by 11% during this period and will amount to almost $1.8 billion.

Contrast Injectors Market Reached $830 Million in 2015

The GlobalData study says that sales of contrast injectors are growing due to an increase in the number of examinations using computed tomography, magnetic resonance imaging and angiography, as well as due to the complication of diseases and the growing use of injection systems in principle.

GlobalData analyst Sarah Janer notes that contrast injectors usually come with CT scanners, while in the case of magnetic resonance imaging devices, they are sold separately.

Single-bulb injectors occupy most of the contrast injection systems market due to their low cost, making such products more attractive to emerging economies and hospitals with tight funding budgets. At the same time, analysts predict high growth in sales of two-bulb injectors, as medical institutions seek to use more efficient equipment to reduce costs.^[4]

See also

• Contrast Agents (Global Market)

Notes